U.S. tariffs on pharmaceuticals will likely drive up costs and cause shortages of critical Canadian-made drugs, including antibiotics, antidepressants and HIV treatment, according to a new study.
Click Here for More Information
Trump tariffs may drive up costs, cause shortages of critical Canadian-made drugs: study
